XBiotech Inc. (XBIT)
2025-06-30 | ||||
|---|---|---|---|---|
| Income tax (expense) benefit | 28 | |||
| Research and development | 5,336 | |||
| General and administrative | 1,000 | |||
| Total operating expenses | 6,336 | |||
| Loss from operations | -6,336 | |||
| Other (expense) income | -3 | |||
| Interest income | 1,530 | |||
| Interest expense | - | |||
| Foreign exchange gain (loss) | 3,081 | |||
| Total other income | 4,608 | |||
| Loss before income taxes | -1,728 | |||
| Net loss | -1,756 | |||
| Net loss per sharebasic and diluted (in dollars per share) | -0.06 | |||
| Shares used to compute basic and diluted net loss per share (in shares) | 30,487,731 | |||